Exicure, Inc. (XCUR) Form 8-K Summary
Business Context and Reporting Period
Exicure, Inc., a Delaware corporation, filed this Current Report on Form 8-K on December 9, 2024. The filing discloses the entry into a material definitive agreement and the unregistered sale of equity securities. The company is listed on The Nasdaq Stock Market LLC under the symbol XCUR.
Key Financial Metrics and Transaction Details
- Transaction Type: Private placement of common stock.
- Investor: SangSangIn Investment & Securities Co., Ltd. ("SangSang").
- Shares Issued: 433,332 shares of common stock.
- Purchase Price: $4.61 per share.
- Gross Proceeds: Approximately $2 million.
- Closing Timeline: Expected within ten days of execution (December 9, 2024).
- Financial Impact: The filing does not provide current revenue, profit, cash flow, margin, or debt figures. It only details the expected cash inflow from this specific transaction.
Material Changes and Agreements
The primary material change is the execution of a Common Stock Purchase Agreement and a Registration Rights Agreement with SangSang. Key terms include:
- Registration Rights: The Company must file a registration statement for the resale of shares within 60 days of closing.
- Liquidated Damages: If the registration statement is not filed within 90 days of closing, the Company must pay SangSang 0.5% of the aggregate investment amount per 30-day period, subject to caps.
- Exemption: The sale relies on the Section 4(a)(2) exemption of the Securities Act, as SangSang is an accredited investor purchasing for investment purposes.
Guidance, Outlook, and Risks
The filing contains no forward-looking guidance, management commentary on operational outlook, or discussion of general business risks beyond the specific terms of the agreement. The primary contingency noted is the potential obligation to pay liquidated damages if the registration filing deadline is missed.
Investor Verification Checklist
- Verify the actual closing date and receipt of the approximately $2 million in proceeds.
- Confirm the filing of the registration statement within the 60-day deadline to avoid liquidated damages.
- Review the full text of the Common Stock Purchase Agreement (Exhibit 10.1) and Registration Rights Agreement (Exhibit 10.2) for additional covenants or restrictions.
- Check subsequent filings for any updates on the company's liquidity position following this capital raise.